# Adverse outcomes in patients with atrial fibrillation and a pacemaker: a cohort study

## TL;DR

This study examines the risks of adverse cardiovascular outcomes in patients with atrial fibrillation who have a pacemaker, finding higher rates of events but no independent link to the pacemaker itself.

## Contribution

The study provides new insights into the prognosis of atrial fibrillation patients with pacemakers using a large, longitudinal cohort.

## Key findings

- Patients with atrial fibrillation and a pacemaker had higher incidence rates of MACE and HF.
- After adjustment, pacemakers were not independently associated with adverse outcomes.

## Abstract

Patients with atrial fibrillation (AF) are at a high risk of adverse cardiovascular outcomes. Little is known about the specific population of AF patients with implanted pacemaker (PM) and their prognosis. Therefore, we aimed to compare the risks of adverse outcomes in AF patients with and without PM.

Data from two Swiss prospective, multicentre cohort studies (Swiss-AF, Beat-AF) (n = 3675) with yearly follow-ups (FUs) up to 8 years were analysed. The first main outcome was major adverse cardiovascular events (MACE), a composite of stroke or transient ischaemic attack, myocardial infarction, cardiovascular death, and systemic embolism. The second main outcome was hospitalization for heart failure (HF). Secondary outcomes were the individual components of MACE. We performed time-updated Cox regression analyses to investigate the association of PM and outcomes. Median age was 71.4 years, 28.8% female, 445 (12.1%) patients had a PM at baseline, and 238 additional patients (7.4%, 1.05%/year) received a PM over a median FU of 7 years. Patients with a PM had higher incidence rates for MACE and HF (5.97 and 5.08 per 100 patient-years, respectively), compared to patients without a PM (3.37 and 2.61 per 100 patient-years, respectively). After multivariable adjustment, we found no independent association of PM and MACE (aHR [95% CI] 1.12 [0.95–1.33; P = 0.183]) or HF (aHR [95% CI] 1.14 [0.94–1.37; P = 0.180]). We found consistent results for the individual components of MACE.

Patients with AF and a PM experienced an increased rate of adverse cardiovascular outcomes. However, the PM itself was not independently associated with these outcomes.

Graphical Abstract